Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 August 2021 | Story Dr Cindé Greyling | Photo Supplied
A woman of impact, quality and care - Dr Lentsu Nchabeleng.

Dr Lentsu Nchabeleng currently serves as the Deputy Director in the Gender Equality and Anti-Discrimination Office within the Unit for Institutional Change and Social Justice at the University of the Free State (UFS). She manages the functions of the office to deliver high-quality services that advance gender equality and anti-discrimination based on human-rights principles.

What is the best thing about your job?
To bring about positive change by using collective individualism to make a collective impact on the university community. This includes recognising diverse views that fall outside the norm to solve issues relating to gender inequality. Thus, every engagement and response that takes place can help create change.

What is the best and worst decision you have ever made?
The best decision I have ever made was to listen to my inner voice and tuning into the wisdom of my body. The worst decision I have ever made was to negotiate my worth and value, which at that particular moment I thought were synonymous.

What was/is the biggest challenge of your career?
There are so many challenges. I don’t know where to begin.

What does the word woman mean to you?
Being a woman, to me, means a lot of things. It means being a force to be reckoned with. The embodiment of resilience, courage, and love.

Which woman inspires you, and why?
My mother inspires me. She’s an inadvertent feminist. I feel connected to more women through her because of her ability to visibilise the presence of women in all spheres of life. She carries her identities – mom, sister, wife, teacher, friend, grandmother, gardener, leader, listener – with so much ease and I admire her for that.

What advice would you give to the 15-year-old you?
Other people’s perception of you ain’t none of your business.

What is the one self-care thing that you do? 
Watering my roses helps me relax and recharge. I have recently learned the importance of silence and it’s benefits to the mind and body. I usually take 15 minutes every day to sit in stillness and self-reflect. This helps me to delve deeper into my value system and needs, which helps activate myself and social awareness.

What makes you a woman of quality, impact, and care?
I would say that my ability to be vulnerable, to accept my weaknesses, my strong sense of independence and speaking my truth, makes me a woman of quality, impact, and care.
 
 


I cannot live without … my family.
My secret weapon is … it will not be a secret weapon if I reveal it …
I always have … a bottle of water.
I will never … take my life for granted. 
I hope … to see the end of the gender pay gap.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept